Cargando…
β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease
INTRODUCTION: Blood–brain barrier (BBB) dysfunction may occur at the onset of Alzheimer’s disease (AD). Pericytes are a vital part of the neurovascular unit and the BBB, acting as gatekeepers of the BBB. Amyloid β (Aβ) deposition and neurofibrillary tangles in the brain are the central pathological...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134700/ https://www.ncbi.nlm.nih.gov/pubmed/35619150 http://dx.doi.org/10.1186/s13578-022-00807-5 |
_version_ | 1784713815394353152 |
---|---|
author | Li, Jianhua Li, Mengyu Ge, Yangyang Chen, Jiayi Ma, Jiamin Wang, Chenchen Sun, Miaomiao Wang, Li Yao, Shanglong Yao, Chengye |
author_facet | Li, Jianhua Li, Mengyu Ge, Yangyang Chen, Jiayi Ma, Jiamin Wang, Chenchen Sun, Miaomiao Wang, Li Yao, Shanglong Yao, Chengye |
author_sort | Li, Jianhua |
collection | PubMed |
description | INTRODUCTION: Blood–brain barrier (BBB) dysfunction may occur at the onset of Alzheimer’s disease (AD). Pericytes are a vital part of the neurovascular unit and the BBB, acting as gatekeepers of the BBB. Amyloid β (Aβ) deposition and neurofibrillary tangles in the brain are the central pathological features of AD. CD36 promotes vascular amyloid deposition and leads to vascular brain damage, neurovascular dysfunction, and cognitive deficits. However, the molecular mechanism by which pericytes of the BBB are disrupted remains unclear. OBJECTIVES: To investigate the effect of low-dose Aβ1-40 administration on pericyte outcome and the molecular mechanism of BBB injury. METHODS: We selected 6-month-old and 9-month-old APP/PS1 mice and wild-type (WT) mice of the same strain, age, and sex as controls. We assessed the BBB using PET/CT. Brain pericytes were extracted and cocultured with endothelial cells (bEnd.3) to generate an in vitro BBB model to observe the effect of Aβ1-40 on the BBB. Furthermore, we explored the intracellular degradation and related molecular mechanisms of Aβ1-40 in cells. RESULTS: BBB permeability and the number of pericytes decreased in APP/PS1 mice. Aβ1-40 increased BBB permeability in an in vivo model and downregulated the expression of CD36, which reversed the Aβ-induced changes in BBB permeability. Aβ1-40 was uptaked in pericytes with high CD36 expression. We observed that this molecule inhibited pericyte proliferation, caused mitochondrial damage, and increased mitophagy. Finally, we confirmed that Aβ1-40 induced pericyte mitophagy-dependent ferroptosis through the CD36/PINK1/Parkin pathway. CONCLUSION: PDGFRβ (a marker of pericytes), CD36, and Aβ colocalized in vitro and in vivo, and Aβ1-40 caused BBB disruption by upregulating CD36 expression in pericytes. The mechanism by which Aβ1-40 destroys the BBB involves the induction of pericyte mitophagy-dependent ferroptosis through the CD36/PINK1/Parkin pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00807-5. |
format | Online Article Text |
id | pubmed-9134700 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91347002022-05-27 β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease Li, Jianhua Li, Mengyu Ge, Yangyang Chen, Jiayi Ma, Jiamin Wang, Chenchen Sun, Miaomiao Wang, Li Yao, Shanglong Yao, Chengye Cell Biosci Research INTRODUCTION: Blood–brain barrier (BBB) dysfunction may occur at the onset of Alzheimer’s disease (AD). Pericytes are a vital part of the neurovascular unit and the BBB, acting as gatekeepers of the BBB. Amyloid β (Aβ) deposition and neurofibrillary tangles in the brain are the central pathological features of AD. CD36 promotes vascular amyloid deposition and leads to vascular brain damage, neurovascular dysfunction, and cognitive deficits. However, the molecular mechanism by which pericytes of the BBB are disrupted remains unclear. OBJECTIVES: To investigate the effect of low-dose Aβ1-40 administration on pericyte outcome and the molecular mechanism of BBB injury. METHODS: We selected 6-month-old and 9-month-old APP/PS1 mice and wild-type (WT) mice of the same strain, age, and sex as controls. We assessed the BBB using PET/CT. Brain pericytes were extracted and cocultured with endothelial cells (bEnd.3) to generate an in vitro BBB model to observe the effect of Aβ1-40 on the BBB. Furthermore, we explored the intracellular degradation and related molecular mechanisms of Aβ1-40 in cells. RESULTS: BBB permeability and the number of pericytes decreased in APP/PS1 mice. Aβ1-40 increased BBB permeability in an in vivo model and downregulated the expression of CD36, which reversed the Aβ-induced changes in BBB permeability. Aβ1-40 was uptaked in pericytes with high CD36 expression. We observed that this molecule inhibited pericyte proliferation, caused mitochondrial damage, and increased mitophagy. Finally, we confirmed that Aβ1-40 induced pericyte mitophagy-dependent ferroptosis through the CD36/PINK1/Parkin pathway. CONCLUSION: PDGFRβ (a marker of pericytes), CD36, and Aβ colocalized in vitro and in vivo, and Aβ1-40 caused BBB disruption by upregulating CD36 expression in pericytes. The mechanism by which Aβ1-40 destroys the BBB involves the induction of pericyte mitophagy-dependent ferroptosis through the CD36/PINK1/Parkin pathway. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13578-022-00807-5. BioMed Central 2022-05-26 /pmc/articles/PMC9134700/ /pubmed/35619150 http://dx.doi.org/10.1186/s13578-022-00807-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Li, Jianhua Li, Mengyu Ge, Yangyang Chen, Jiayi Ma, Jiamin Wang, Chenchen Sun, Miaomiao Wang, Li Yao, Shanglong Yao, Chengye β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease |
title | β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease |
title_full | β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease |
title_fullStr | β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease |
title_full_unstemmed | β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease |
title_short | β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood–brain barrier destruction in Alzheimer’s disease |
title_sort | β-amyloid protein induces mitophagy-dependent ferroptosis through the cd36/pink/parkin pathway leading to blood–brain barrier destruction in alzheimer’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134700/ https://www.ncbi.nlm.nih.gov/pubmed/35619150 http://dx.doi.org/10.1186/s13578-022-00807-5 |
work_keys_str_mv | AT lijianhua bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT limengyu bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT geyangyang bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT chenjiayi bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT majiamin bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT wangchenchen bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT sunmiaomiao bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT wangli bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT yaoshanglong bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease AT yaochengye bamyloidproteininducesmitophagydependentferroptosisthroughthecd36pinkparkinpathwayleadingtobloodbrainbarrierdestructioninalzheimersdisease |